Diffusion Pharmaceuticals...

NASDAQ: DFFN · Real-Time Price · USD
4.40
0.41 (10.28%)
At close: Aug 16, 2023, 10:00 PM

Diffusion Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2022 Dec 31, 2021
Net Income
-16.29M -15.59M -24.1M
Depreciation & Amortization
n/a -208.58K 93.42K
Stock-Based Compensation
1.41M 928.05K 897.26K
Other Working Capital
n/a 413.19K -249K
Other Non-Cash Items
n/a n/a 8.69M
Deferred Income Tax
n/a n/a -443.89K
Change in Working Capital
n/a -97.16K 356.37K
Operating Cash Flow
-16.53M -14.97M -14.5M
Capital Expenditures
n/a n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
-48.1M -37.99M n/a
Sales Maturities Of Investments
19.44M 25.75M n/a
Other Investing Acitivies
n/a n/a 4K
Investing Cash Flow
-28.66M -12.24M 4K
Debt Repayment
n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 5K 33.3M
Financial Cash Flow
46.4M 5K 33.3M
Net Cash Flow
1.21M -27.2M 18.8M
Free Cash Flow
-16.53M -14.97M -14.5M